Blood test shows promise for predicting treatment response i

Blood test shows promise for predicting treatment response in patients with advanced HPV-positive throat cancer


Blood test shows promise for predicting treatment response in patients with advanced HPV-positive throat cancer
A sensitive blood test being developed by a team of researchers at the University of Michigan Rogel Cancer Center shows promise for predicting whether patients with metastatic HPV-positive throat cancer will respond to treatment months earlier than standard imaging scans.
That's according to a study, published in
Oncotarget, validating the test in a small group of patients with metastatic human papillomavirus-related oropharyngeal squamous cell carcinoma -- a type of head and neck cancer that develops in the back of the mouth and in the throat.

Related Keywords

Catherine Haring , Muneesh Tewari , Paul Swiecicki , Chandan Bhambhani , Emily Henderson , Department Of Otolaryngology , University Of Michigan Rogel Cancer Center , Michigan Rogel Cancer Center , Chad Brenner , Neck Surgery , Oral Oncology , எமிலி ஹென்டர்சன் , துறை ஆஃப் ஓதோழாரய்ங்கொலொகி , பல்கலைக்கழகம் ஆஃப் மிச்சிகன் ரோஜல் புற்றுநோய் மையம் , மிச்சிகன் ரோஜல் புற்றுநோய் மையம் , கழுத்து அறுவை சிகிச்சை , வாய்வழி புற்றுநோயியல் ,

© 2025 Vimarsana